Market Segmentation:
- By Product Type
- Thrombin-based Hemostats
- Oxidized Regenerated Cellulose-based Hemostats
- Gelatin-based Hemostats
- Collagen-based Hemostats
- Combination Hemostats
- By Application
- Cardiovascular Surgery
- General Surgery
- Orthopedic Surgery
- Neurosurgery
- Gynecological Surgery
- Plastic Surgery
- Others (Dental Surgery, Trauma Surgery)
- By End-User
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Others (Home Healthcare, Research Institutes)
- By Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The current market size of the Absorbable Hemostats industry is USD 2.1 billion.
Increasing prevalence of chronic diseases, Rising number of surgical procedures globally, Technological advancements in hemostats, Growing demand for minimally invasive surgeries
Risk of adverse reactions, Stringent regulatory approvals, High cost of advanced hemostats, Availability of alternative hemostatic agents, Limited awareness, Lack of skilled professionals, Reimbursement challenges
The thrombin-based hemostats segment is the leading component segment in the Absorbable Hemostats Market. It offers high efficacy and compatibility with minimally invasive surgeries.
The Absorbable Hemostats Market is expected to grow at a CAGR of 8.2% from 2024 to 2031, with the market size reaching US$3.9 billion by 2031.
Increasing prevalence of chronic diseases, Rising surgical procedures, Technological advancements, Demand for minimally invasive surgeries, Improving healthcare infrastructure, Aging population, Favorable reimbursement policies, Increasing healthcare expenditure